基本信息
浏览量:38
职业迁徙
个人简介
Dr. Kinney began his industrial career in the CNS group at Wyeth, where he invented unique NMDA antagonist perzinfotel (phase II clinical trials, stroke, pain). At Magainin Pharmaceuticals, he was an inventor of trodusquemine (phase II clinical trials, central control of obesity) and squalamine (phase II clinical trials, eye disease), two shark-derived natural products. He was the CMC leader on the IND project team, delivering drug substance to launch a Phase I clinical trial on time and on budget. The squalamine scale-up campaign required leading an internal process group, partnering with analytical chemistry on method development and stability studies, working with multiple domestic and international collaborators, and writing the CMC section of the IND. In 2000, he joined Johnson & Johnson, where he directed the AlphaV Beta3 Integrin Project, which generated multiple chemical series and 8 publications. Notably, JNJ-26076713 demonstrated utility in preventing proliferative neovascularization and vascular leakage in the eye after oral administration; and was proposed as a development candidate. He also made seminal discoveries with respect to self-assembling collagen-mimetic peptides that stimulate platelet aggregation.
As Founder of IteraMed Consulting, he has succeeded in advancing several projects which resulted in multiple patent filings and funding events. As part of the development activities, Dr. Kinney has led pharmaceutic efforts aimed at the optimum nanoformulation of a rapamycin conjugate for development at NanoPhagix. As a consultant to Kannalife Sciences, he discovered a new patented series of Cannabidiol-like molecules, including KLS-13019, with improved safety, bioavailability, potency and regulatory path. Most recently, Dr. Kinney co-founded Enterin Inc., which has been funded with VC funds to advance ENT-01 in Phase II clinical trials in Parkinson’s Disease. He is a contributing faculty member in the Master’s Program at the Geisinger Commonwealth School of Medicine.
研究兴趣
论文共 121 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Research Square (Research Square) (2024)
Silvia Errico,Giacomo Lucchesi,Davide Odino,Enass Youssef Osman,Roberta Cascella, Lorenzo Neri,Claudia Capitini,Martino Calamai,Francesco Bemporad,Cristina Cecchi,William A. Kinney,Denise Barbut,Annalisa Relini,Claudio Canale,Gabriella Caminati,Ryan Limbocker,Michele Vendruscolo,Michael Zasloff,Fabrizio Chiti
Journal of medicinal chemistryno. 14 (2023): 9519-9536
Tetrahedron Letters (2023): 154369-154369
Michael Camilleri,Thyagarajan Subramanian,Fernando Pagan,Stuart Isaacson,Ramon Gil,Robert A. Hauser, Mary Feldman,Mark Goldstein,Rajeev Kumar,Daniel Truong,Nisha Chhabria,Benjamin L. Walter, Jonathan Eskenazi,Robert Riesenberg,Daniel Burdick,Winona Tse,Eric Molho,Bradley Robottom,Perminder Bhatia, Srinath Kadimi,Kevin Klos,David Shprecher, Otto Marquez-Mendoza, Gonzalo Hidalgo,Stephen Grill,George Li, Howard Mandell, Mary Hughes, Sharisse Stephenson, Joel Vandersluis,Michael Pfeffer,Andrew Duker,Vikram Shivkumar,William Kinney,James MacDougall,Michael Zasloff,Denise Barbut
Robert A. Hauser, Dean Sutherland,Juan A. Madrid,Maria Angeles Rol,Steven Frucht,Stuart Isaacson,Fernando Pagan, Brian N. Maddux,George Li,Winona Tse,Benjamin L. Walter,Rajeev Kumar,Daniel Kremens,Mark F. Lew,Aaron Ellenbogen,Odinachi Oguh, Alberto Vasquez,William Kinney,Matt Lowery, Maria Resnick
Clinical parkinsonism & related disorders (2019): 2-7
William A Kinney,Mark E McDonnell, Hua Marlon Zhong, Chaomin Liu, Lanyi Yang, Wei Ling, Tao Qian, Yu Chen, Zhijie Cai,Dean Petkanas,Douglas E Brenneman
加载更多
作者统计
#Papers: 121
#Citation: 3448
H-Index: 32
G-Index: 52
Sociability: 6
Diversity: 2
Activity: 19
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn